Company: ZVRA
Filing Date: 2025-04-21
Form Type: DEFC14A
Source: 0001193125-25-086293
Chunk: 75

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-21
Form: DEFC14A
Chunk 75
---
., MBA    |     | Chief Commercial Officer                              |
| Rahsaan W. Thompson          |     | Chief Legal Officer, Secretary and Compliance Officer |

Information Regarding Ownership of Zevra Securities by Participants The number of shares of the Company’s common stock beneficially owned by its directors (including our director nominees) and executive officers that are considered to be participants as of the Record Date is set forth under the “Security Ownership of Certain Beneficial Owners and Management” table and notes thereto elsewhere in this proxy statement.The number of shares held directly by the executive officers and employees and those considered to be associates of participants that are not individually named in the “Security Ownership of Certain Beneficial Owners and Management” table and notes thereto in this proxy statement are shown below:

| Name                      |     | Shares Beneficially Owned |     | Shares Owned of Record But Not Beneficially |
| Joshua Schafer, M.S., MBA |     |                   179,486 |     | N/A                                         |

A-2

Information Regarding Transactions in Zevra Securities by Participants The following table sets forth information regarding all securities of the Company purchased or sold by each of the participants listed above under “Directors and Nominees” and “Executive Officers and Employees” during the past two years, except for unvested performance-based awards that are not reportable under Section 16 of the Exchange Act. Unless otherwise indicated, all transactions were in the public market or pursuant to the Company’s equity compensation plans, and none of the purchase price or market value of those securities are represented by funds borrowed or otherwise obtained for the purpose of acquiring or holding such securities. Refer to “Key to Transaction Descriptions” below the table for an explanation of transaction descriptions.

| Name               |     | Transaction Date |     | # of Shares |     | Transaction Description |
| Wendy Dixon, Ph.D. |     | 04/25/2023       |     |      22,500 |     | SOG                     |
| Tamara A. Favorito |     | 04/25/2023       |     |      39,200 |     | SOG                     |
| John B. Bode       |     | 05/03/2023       |     |      58,800 |     | SOG                     |
| Wendy Dixon, Ph.D. |     | 05/03/2023       |     |      36,300 |     | SOG                     |
| Corey M. Watton    |